SCRI

SCRI Impact Report 2023

Issue link: https://uberflip.scri.com/i/1521059

Contents of this Issue

Navigation

Page 1 of 27

SCRI Leadership Team Dee Anna Smith Chief Executive Officer, SCRI Howard "Skip"Burris, III, MD President, SCRI David Spigel, MD Chief Scientific Officer, SCRI Vivek Subbiah, MD Chief, Early-Phase Drug Development, SCRI Anne Hoang Chief Operating Officer, SCRI Andrew Mckenzie, PhD Vice President, Personalized Medicine, SCRI; Scientific Director, Genospace Amber Woodward-Smith Vice President, Finance, SCRI Paul Ashley Chief Information Officer, SCRI Pamela Paul-McNeill Vice President, Quality Assurance, SCRI David Adler Vice President, Business Development, SCRI Ishwaria Subbiah, MD Executive Director, Cancer Care Equity & Professional Wellness, SCRI Jennifer Cole Senoir Vice President, Research Operations, SCRI Marcy Vallone Senior Vice President, Development Innovations, SCRI

Articles in this issue

view archives of SCRI - SCRI Impact Report 2023